Drugs

Article	Citations
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression	463
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments	452
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema	339
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments	324
Eftrenonacog Alfa: A Review in Haemophilia B	231
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”	197
Teclistamab: First Approval	170
New Therapies on the Horizon for Primary Biliary Cholangitis	149
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using	147
Spesolimab for the Treatment of Generalized Pustular Psoriasis	131
Targeting DNA Damage Response Deficiency in Thoracic Cancers	129
Bimekizumab for the Treatment of Psoriasis	129
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations	126
Senaparib: First Approval	120
Vorasidenib: First Approval	115
Epcoritamab: First Approval	114
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences	110
Aprocitentan: First Approval	108
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine	107
Cosibelimab: First Approval	107
Lenacapavir: First Approval	101
Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies	96
Androgenetic Alopecia: Therapy Update	96
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure	96
Acoltremon: First Approval	95

QT Prolongation and Risk of Death with the Use of Methadone for Chronic Cancer and Noncancer Pain: Myths or Reality?	94
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial	94
Olipudase Alfa: First Approval	90
Ivarmacitinib Sulfate: First Approval	86
Atogepant: First Approval	85
Drugs in Development to Manage Acute Pain	85
Repotrectinib: First Approval	84
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer	83
Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis	83
Finerenone: First Approval	83
Danicopan: First Approval	83
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids	81
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection	79
Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema	77
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?	76
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?	75
Olverembatinib: First Approval	75
Cancer Pain Treatment Strategies in Patients with Cancer	75
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification	74
Mosunetuzumab: First Approval	71
Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections	70
Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT’s Aptitude in Pharmacology	69
Correction to: Tapinarof Cream 1%: First Approval	68
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes	68
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough	67
Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis	66
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?	65
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer	64
Correction to: Prevention and Treatment of Monkeypox	64
Managing Burning Mouth Syndrome: Current and Future Directions	61
Pozelimab: First Approval	61
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options	60
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned	60
The Place of Cannabinoids in the Treatment of Gynecological Pain	58
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A	56
Tovorafenib: First Approval	56
Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy	55
Sunvozertinib: First Approval	55
Correction to: Concizumab: First Approval	55
Dorzagliatin: First Approval	55
The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab	55
Correction: From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology	54
Correction to: Remdesivir: A Review in COVID-19	54
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?	54
Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study	53
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses	52
Disitamab Vedotin: First Approval	52
Asciminib: First Approval	52
Catumaxomab: First Approval	51
Ozoralizumab: First Approval	51

Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	51
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’	50
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond	50
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence	50
Givinostat: First Approval	50
Gepirone Extended-Release: First Approval	49
Aumolertinib: A Review in Non-Small Cell Lung Cancer	49
Tirzepatide: A Review in Type 2 Diabetes	49
Birch Bark Extract: A Review in Epidermolysis Bullosa	48
Correction: Teprotumumab: A Review in Thyroid Eye Disease	47
Correction to: Sotorasib: First Approval	47
Futibatinib: First Approval	45
Atrasentan: First Approval	45
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study	44
Avacincaptad Pegol: First Approval	44
Ensitrelvir Fumaric Acid: First Approval	44
Correction to: Efmoroctocog Alfa: A Review in Haemophilia A	44
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy	43
Tisotumab Vedotin: First Approval	42
Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes	41
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets	41
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults	41
Fezolinetant: First Approval	41
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations	39
Zastaprazan: First Approval	39
Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets	39
Eye Involvement and Management in Inherited Epidermolysis Bullosa	39
Managing Pain in Fibromyalgia: Current and Future Options	38
Effectiveness of Interventions to Reduce Opioid Use After Orthopaedic Surgery: A Systematic Review of Randomised Controlled Trials	38
Imeglimin Hydrochloride: First Approval	38
Lotilaner Ophthalmic Solution 0.25%: First Approval	37
Imetelstat: First Approval	37
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1	37
Gastrointestinal Dysfunction in Parkinson’s Disease	37
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis	37
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries	37
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?	36
Beremagene Geperpavec: First Approval	35
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease	35
Correction: Iptacopan: First Approval	35
Tebentafusp: First Approval	34
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease	34
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases	34
Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues	33
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin	33
Acknowledgement to Referees	33
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry	33
Crinecerfont: First Approval	32
Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence”	31
Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials	31
Revumenib: First Approval	31
Retifanlimab: First Approval	30
Revolutionary Changes in the Management of Lupus Nephritis: Towards De-Glucocorticoid or No-Glucocorticoid	30
Nogapendekin alfa Inbakicept: First Approval	30
Donafenib: First Approval	30
Mavorixafor: First Approval	30
Diagnosis and Treatment of AL Amyloidosis	30
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews	30
Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes	29
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management	29
Avatrombopag: A Review in Thrombocytopenia	29
Correction: Zastaprazan: First Approval	28
Correction to: Abrocitinib: First Approval	28
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study	28
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study	28
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update	28
Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis	28
Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”	28
Correction to: Sparsentan: First Approval	28
Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial	27
Daridorexant: First Approval	27
Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval	27
Correction to: Spesolimab: First Approval	27
Ravulizumab: A Review in Generalised Myasthenia Gravis	27
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy	26
Keverprazan Hydrochloride: First Approval	26
Zolbetuximab: First Approval	26
Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy	26
Methadone for Cancer Pain Management in Children: A Review of Literature	26
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer	26

Remdesivir: A Review in COVID-19	26
Antibacterials with Novel Chemical Scaffolds in Clinical Development	26
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective	25
Gefapixant: First Approval	25
A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation	25
Marstacimab: First Approval	25
Ripretinib: A Review in Gastrointestinal Stromal Tumours as Fourth-or Later-Line of Therapy	25
Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clos	25
Regdanvimab: First Approval	24
Abrocitinib: First Approval	24
Molnupiravir: First Approval	24
Novel Drug Therapeutics in Celiac Disease: A Pipeline Review	24
Treatment of Osteoporosis and Osteoarthritis in the Oldest Old	24
Spesolimab: First Approval	24
Refractory Systemic Lupus Erythematosus: Identification and Pharmacological Management	24
Odevixibat: First Approval	24
Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases	24
Comment on: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”	23
Correction to: Rozanolixizumab: First Approval	23
Lecanemab: First Approval	23
Pucotenlimab: First Approval	23
Nadofaragene Firadenovec: First Approval	23
Correction to: Mavacamten: First Approval	23
Elranatamab: First Approval	23
Correction to: Contezolid: First Approval	22
Ritlecitinib: First Approval	22
Amubarvimab/Romlusevimab: First Approval	22
Tofersen: First Approval	22
Acknowledgement to Referees	22
Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis	22
Tixagevimab + Cilgavimab: First Approval	22
Comment on “Trientine Tetrahydrochloride, From Bench to Bedside: A Narrative Review”	22
Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions	22
Chiglitazar: First Approval	22
Chronic Obstructive Pulmonary Disease (COPD): Developments in Pharmacological Treatments	21
Correction to: Ozanimod: A Review in Ulcerative Colitis	21
Differentiating IL-23 Inhibitors in Crohn’s Disease	21
Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline	21
New Developments in Glucagon Treatment for Hypoglycemia	21
Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study	21
Elafibranor: First Approval	21
Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer	20
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis	20
Gepotidacin: First Approval	20
Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’	20
Talquetamab: First Approval	20
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders	20
Furmonertinib: First Approval	20
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?	19
Valoctocogene Roxaparvovec: First Approval	19
Eplontersen: First Approval	19
PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis	18
20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults	18
Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective	18
Association of Glucagon-Like Peptide-1 Receptor Agonist with Progression to Liver Cirrhosis and Alcohol-Related Admissions in Patients with Alcohol Use Disorder and Diabetes: A Retrospective Cohort St	18
Sipavibart: First Approval	18
Vamorolone: First Approval	18
A Meta-analysis Exploring the Efficacy of Neuropathic Pain Medication for Low Back Pain or Spine-Related Leg Pain: Is Efficacy Dependent on the Presence of Neuropathic Pain?	18
Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action	18
Tunlametinib: First Approval	18
Mirvetuximab Soravtansine: First Approval	17
Sulbactam/Durlobactam: First Approval	17
TKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors	17
Inhaled Phosphodiesterase Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease	17
How Psychedelics Modulate Multiple Memory Mechanisms in Posttraumatic Stress Disorder	17
Vosoritide: First Approval	17
PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease	17
Dimdazenil: First Approval	17
Motixafortide: First Approval	17
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections	17
Tegileridine: First Approval	16
Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis	16
Authors’ Reply to Colak et al.: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”	16
Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies	16
Vimseltinib: First Approval	16
Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions	16
Iptacopan: First Approval	16
Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials	16
Fitusiran: First Approval	16
Tirzepatide: First Approval	16
Nemolizumab: First Approval	15
Use of Levosimendan in Patients with Pulmonary Hypertension: What is the Current Evidence?	15
Results from Expanded Access Programs: A Review of Academic Literature	15
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy	15
Linzagolix: First Approval	15
Drugs in Development to Treat IgA Nephropathy	15
Cabotegravir Extended-Release Injectable Suspension: A Review in HIV-1 Pre-Exposure Prophylaxis	15
Drug-Induced Pigmentation: A Review	15
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians	15
Diabetes of the Exocrine Pancreas: Implications for Pharmacological Management	14
GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy	14
Belzutifan: First Approval	14
Correction to: Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema	14
HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic	14
Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review	14